CN1336922A - 促血清脂质减少及抗氧化的吗啉衍生物 - Google Patents

促血清脂质减少及抗氧化的吗啉衍生物 Download PDF

Info

Publication number
CN1336922A
CN1336922A CN00802766A CN00802766A CN1336922A CN 1336922 A CN1336922 A CN 1336922A CN 00802766 A CN00802766 A CN 00802766A CN 00802766 A CN00802766 A CN 00802766A CN 1336922 A CN1336922 A CN 1336922A
Authority
CN
China
Prior art keywords
compound
derivatives
formula
substituted morpholine
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN00802766A
Other languages
English (en)
Chinese (zh)
Inventor
M·克里塞利斯
E·莱卡
P·库罗纳其斯
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Elpen SA
Original Assignee
Elpen SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Elpen SA filed Critical Elpen SA
Publication of CN1336922A publication Critical patent/CN1336922A/zh
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
    • C07D265/34—1,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings
    • C07D265/36—1,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings condensed with one six-membered ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
    • C07D265/30—1,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings
    • C07D265/32—1,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings with oxygen atoms directly attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
CN00802766A 1999-01-14 2000-01-14 促血清脂质减少及抗氧化的吗啉衍生物 Pending CN1336922A (zh)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GR990100015 1999-01-14
GR99100015 1999-01-14
GR990100227 1999-07-05
GR99100227 1999-07-05

Publications (1)

Publication Number Publication Date
CN1336922A true CN1336922A (zh) 2002-02-20

Family

ID=26316685

Family Applications (1)

Application Number Title Priority Date Filing Date
CN00802766A Pending CN1336922A (zh) 1999-01-14 2000-01-14 促血清脂质减少及抗氧化的吗啉衍生物

Country Status (8)

Country Link
US (1) US6693192B1 (https=)
EP (1) EP1140877A1 (https=)
JP (1) JP2002534516A (https=)
CN (1) CN1336922A (https=)
AU (1) AU770267B2 (https=)
BR (1) BR0007490A (https=)
CA (1) CA2359476C (https=)
WO (1) WO2000042030A1 (https=)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102127031A (zh) * 2011-01-17 2011-07-20 江苏江神药物化学有限公司 一种麻黄碱类化合物季胺盐及其合成方法和应用

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE602005016402D1 (de) 2004-05-24 2009-10-15 Genvault Corp Stabile lagerung von protein und stabile lagerung von nukleinsäure in wiedergewinnbarer form
WO2010031007A2 (en) 2008-09-12 2010-03-18 Genvault Corporation Matrices and media for storage and stabilization of biomolecules
EP2419400A1 (en) 2009-04-15 2012-02-22 Research Triangle Institute Monoamine reuptake inhibitors
CA2800219C (en) 2010-05-21 2019-03-12 Research Triangle Institute 1 - phenylmorpholine derivatives as hydroxybupropion analogues for treating drug dependence
JP2013526583A (ja) 2010-05-21 2013-06-24 リサーチ・トライアングル・インスティチュート フェニルモルホリンおよびその類似体
GR20100100333A (el) * 2010-06-10 2012-01-31 Αγγελικη Παναγιωτη Κουρουνακη Μορφολινικα παραγωγα υποκατεστημενων διαφαινυλικων ενωσεων

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3717560A1 (de) * 1987-05-25 1988-12-08 Thomae Gmbh Dr K Neue 2-hydroxy-morpholine, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102127031A (zh) * 2011-01-17 2011-07-20 江苏江神药物化学有限公司 一种麻黄碱类化合物季胺盐及其合成方法和应用

Also Published As

Publication number Publication date
BR0007490A (pt) 2001-10-16
AU1996000A (en) 2000-08-01
EP1140877A1 (en) 2001-10-10
US6693192B1 (en) 2004-02-17
JP2002534516A (ja) 2002-10-15
CA2359476A1 (en) 2000-07-20
CA2359476C (en) 2006-01-03
WO2000042030A1 (en) 2000-07-20
AU770267B2 (en) 2004-02-19

Similar Documents

Publication Publication Date Title
AU701186B2 (en) Novel 2,3,5-trimethyl-4-hydroxyanilide derivatives, their preparation and their application in therapeutics
DK165594B (da) (-)-benzhydrylsulfinylacetamid, fremgangsmaade til fremstilling heraf, terapeutisk praeparat indeholdende denne forbindelse, samt anvendelse af forbindelsen til fremstilling af et laegemiddel
CY1444A (en) Salts of 2-(2,6-dichloroanilino)phenylacetic acit and their production
CH651561A5 (fr) Derives des nor-tropane et granatane et leur procede de preparation.
CN1011784B (zh) 制备抗过敏和抗支气管痉挛药n-二苯甲基二氮杂环烷基烷基n-酰苯胺的方法
CA2692636A1 (en) Process for producing cisatracurium and associated intermediates
CN1336922A (zh) 促血清脂质减少及抗氧化的吗啉衍生物
CA1263957A (fr) Derives quinolylglycinamides, leur procede de preparation et leur application therapeutique en tant que psychotropes
FR2491066A1 (fr) Benzoxazolinones substituees en 6 par une chaine aminoalcool ou aminocetone, leur preparation et leur application en therapeutique
JPS59222484A (ja) テトラヒドロナフチルカルボン酸フエニルエステル誘導体
FR2595695A1 (fr) Derives de n-(((hydroxy-2 phenyl) (phenyl) methylene) amino-2) ethyl) acetamide, leur preparation et leur application en therapeutique
FR2623808A1 (fr) Nouveaux derives flavonoides (benzyl-4 piperazinyl-1)-2 oxo-2 ethylene substitues, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent
JP2002534516A5 (https=)
JPH0567634B2 (https=)
FR2645743A1 (fr) Compositions therapeutiques a base de derives di-substitues des n,n(prime)-ditrimethoxybenzoyle piperazines
US5281617A (en) N-succinimidyl and N-phthalimidyl esters of 2-phenylalkanoic acid derivatives as inhibitors of human leukocyte elastase
LU84841A1 (fr) Nouveaux derives de l'acide 4-hydrox 3-quinoleine carboxyclique substitues en 2,leur preparation,leur application comme medicaments,les compositions les renfermant et les intermediaires obtenus
JPS63185948A (ja) 置換アミノプロピオンアミドおよびその製造方法
CA1055938A (en) Morpholinone derivatives and their production
DK149845B (da) Analogifremgangsmaade til fremstilling af 2-((4-quinolinyl)-amino)-5-flourbenzoesyrederivater
US4017623A (en) Esters of 2-[(4-quinolyl)amino]-benzoic acids in analgesic and anti-inflammatory compositions
HU209930B (en) Process for producing of 2-mercapto-2-(1-isoquinolylidene)-acetonitrile derivatives and pharmaceutical compositions comprising them
AU756726B2 (en) Aromatic derivatives and iron complexes thereof for the use as normalising agents of the iron level
US4092324A (en) Diheterocyclic esters of 4-(1,1-bis-(phenoxy-propionic or -butoyric acid)-cyclohexane)α-methyl substituted
WO1994007870A1 (fr) Derives de dihydro-1,2 oxo-2 amino-3 quinoxalines, leur preparation et leur application en therapeutique

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication